Aashka Hospitals Limited (BOM:543346)
India · Delayed Price · Currency is INR 75.00
+0.02 (0.03%)
At close: Jun 3, 2026
Aashka Hospitals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 230.1 | 226.47 | 228.74 | 189.45 | 397.34 |
Other Revenue | 22.69 | - | - | - | - |
| 252.79 | 226.47 | 228.74 | 189.45 | 397.34 | |
Revenue Growth (YoY) | 11.63% | -0.99% | 20.74% | -52.32% | -2.35% |
Cost of Revenue | 74.02 | 69.41 | 67.92 | 68.47 | 124.51 |
Gross Profit | 178.77 | 157.06 | 160.82 | 120.98 | 272.82 |
Selling, General & Admin | - | 3.29 | 4.53 | 3.9 | 1.24 |
Other Operating Expenses | 103.68 | 105.46 | 111.56 | 113.55 | 185.87 |
Operating Expenses | 133.36 | 138.21 | 145.28 | 146.8 | 216.11 |
Operating Income | 45.41 | 18.86 | 15.54 | -25.82 | 56.71 |
Interest Expense | -11.81 | -14.99 | -25.81 | -29.79 | -27.63 |
Interest & Investment Income | - | 23.05 | 41.18 | 30.86 | 0.18 |
Other Non Operating Income (Expenses) | -0 | 2.52 | -2.33 | -0.94 | -1.2 |
EBT Excluding Unusual Items | 33.6 | 29.44 | 28.58 | -25.69 | 28.06 |
Gain (Loss) on Sale of Assets | - | - | -0.11 | - | - |
Other Unusual Items | 5.96 | 9.26 | - | - | - |
Pretax Income | 39.56 | 38.7 | 28.46 | -25.69 | 28.39 |
Income Tax Expense | 6.17 | 6.04 | 4.88 | - | 4.74 |
Net Income | 33.39 | 32.66 | 23.58 | -25.69 | 23.65 |
Net Income to Common | 33.39 | 32.66 | 23.58 | -25.69 | 23.65 |
Net Income Growth | 2.23% | 38.52% | - | - | -42.51% |
Shares Outstanding (Basic) | 23 | 23 | 23 | 23 | 21 |
Shares Outstanding (Diluted) | 23 | 23 | 23 | 23 | 21 |
Shares Change (YoY) | -0.08% | - | - | 10.58% | 17.59% |
EPS (Basic) | 1.43 | 1.40 | 1.01 | -1.10 | 1.12 |
EPS (Diluted) | 1.43 | 1.40 | 1.01 | -1.10 | 1.12 |
EPS Growth | 2.31% | 38.52% | - | - | -51.11% |
Free Cash Flow | 49.72 | 78.11 | 65.04 | 9.37 | -645.02 |
Free Cash Flow Per Share | 2.13 | 3.34 | 2.78 | 0.40 | -30.52 |
Gross Margin | 70.72% | 69.35% | 70.30% | 63.86% | 68.66% |
Operating Margin | 17.96% | 8.33% | 6.79% | -13.63% | 14.27% |
Profit Margin | 13.21% | 14.42% | 10.31% | -13.56% | 5.95% |
Free Cash Flow Margin | 19.67% | 34.49% | 28.43% | 4.94% | -162.34% |
EBITDA | 75.09 | 48.31 | 44.72 | 3.52 | 85.71 |
EBITDA Margin | 29.70% | 21.33% | 19.55% | 1.86% | 21.57% |
D&A For EBITDA | 29.68 | 29.46 | 29.18 | 29.34 | 29 |
EBIT | 45.41 | 18.86 | 15.54 | -25.82 | 56.71 |
EBIT Margin | 17.96% | 8.33% | 6.79% | -13.63% | 14.27% |
Effective Tax Rate | 15.60% | 15.60% | 17.16% | - | 16.69% |
Revenue as Reported | 252.79 | 259.85 | 270.9 | 220.48 | 398.61 |
Advertising Expenses | - | - | - | 3.63 | 0.47 |